Revolution Medicines, Inc. is 25.8x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($30.74 B vs $1.19 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | COAG | RVMD |
|---|---|---|
| Market cap | $1.19 B | $30.74 B |
| US-listed rank | #2507 | #453 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | - | -$1.13B |
| SEC filings | 38 | 782 |
Revolution Medicines, Inc. is 25.8x more valuable than Hemab Therapeutics Holdings, Inc. by market capitalization ($30.74 B vs $1.19 B).
Full pages: Hemab Therapeutics Holdings, Inc. and Revolution Medicines, Inc., or browse the full rankings.